BioWales in London – 9th March – Draft Programme Announced

Showcasing the best of Welsh life science

February 16, 2022

Welsh Life sciences is a thriving and dynamic sector and particularly in the last 2 years, there have been significant developments around clinical innovation, medtech and diagnostics. This event showcases exciting new innovations, and companies looking for investment and collaboration opportunities.

We will also have presentations from the Welsh NHS on how to engage with clinicians, collaborate on clinical studies and evaluations and support for regulatory compliance.

Tying in with Wales Week in London, this event will provide opportunities to strengthen the collaborative partnerships between the London and Wales.

BioWales in London

Draft Programme:
Introduction and Welcome

MediWales Life Science Network for Wales:
Gwyn Tudor CEO (Chair)

Welsh Company Showcase

Midatech Pharma Bio-delivery of Medicines:
Steve Ellul, VP of Business Development.

Jellagen Next Generation Collagen for Regenerative Medicine:
Andrew Mearns Spragg, CEO.

CanSense Innovation in Cancer Diagnostics

BlueBox Optics Image guided surgery for Breast Cancer:
Ron Yandle, CEO.

Creo Medical Advanced Energy in Therapeutic Endoscopy TBC.

Forth with Life Female Hormone Mapping – Home Blood Tests:
Sarah Bolt, CEO & Founder.

Glucose Republic Glucose Management through Digital and AI:
David Haines, CEO.

Biophys Supporting Global Life Science from Wales:
Michael Graz, CEO.

Funding and Finance

Panel discussion: support for companies on their investment journey and investment rounds.

Working with the Welsh NHS

Cardiff and Vale University Health Board:
Mark Briggs, Innovation Lead.

Velindre Cancer Centre:
Robyn Davies, Innovation Lead.

Networking Reception and Close

The event will be held at the Blake Morgan office in London.

Register for the event here.


by Sam Tudor